Licensed Practical Nurse in Tumwater, WA Accepting Medicare

6 Licensed Practical Nurse nurses found. Showing 1 - 6

Yvonne Rene Arnce, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3285 Ferguson St. S.w., Tumwater, WA 98512 Phone: 360-943-1907

Deborah S Halstead, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 700 Israel Rd Sw, Tumwater, WA 98501 Phone: 360-709-7635

Jessica Tami Wharton, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3285 Ferguson St Sw, Tumwater, WA 98512 Phone: 360-943-1907    Fax: 360-943-1932

Mrs. Alyssa May Lee, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3285 Ferguson St Sw, Tumwater, WA 98512 Phone: 360-943-1907

Anna Tamar Strand, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3285 Ferguson St Sw, Tumwater, WA 98512 Phone: 360-943-1907

Susan Michelle Mixon, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3285 Ferguson St Sw, Tumwater, WA 98512 Phone: 360-280-9889

News Archive

THI to launch saliva-based TeloTest in first quarter 2013

Telome Health, Inc. (THI), developer of the TeloTest diagnostic test that measures average telomere length, announces the planned launch of the saliva-based TeloTest in the first quarter of 2013. Related telomere tests, including percentage of short telomeres, would follow.

Climate change and public health: only fives states have published public health response plans, says study

Trust for America's Health (TFAH) released a new report today that finds only five states have published a strategic climate change plan that includes a public health response. This includes planning for health challenges and emergencies expected to develop from natural disasters, pollution, and infectious diseases as temperatures and sea levels rise.

FDA advisory panel OKs anemia drug peginesatide

Once approved by the FDA, the once-monthly injection could capture a share of the $3 billion U.S. market for anemia drugs used for kidney dialysis patients, currently dominated by Amgen Inc's blockbuster Epogen. Affymax, which developed the drug with partner Takeda Pharmaceutical Co Ltd, is also expected to price its product below Epogen.

Cogstate technology to be applied in paediatric clinical trial in the U.S.

Medical technology company Cogstate Limited has today announced its technology will be used in a large paediatric clinical trial in the United States.

Read more Medical News

› Verified 1 days ago